Capitalone investing the latest sector rotation analysis

The latest sector rotation analysis from CapitalOne Investing highlights a move toward healthcare equities, driven by positive drug trial results and defensive portfolio strategies. The shrewd strategy and solid brand execution are how Vita Coco grew to $560 million in revenue and $64.4 million in earnings over the past 12 months, while only having invested about $130 million in overall capital. That means Vita Coco is earning just over a 50% return on invested capital (ROIC) today. He can be reached at [email protected] and he can be followed on LinkedIn . CapitalOne Investing trading data for June shows accelerated ETF purchases, particularly in S&P 500 and Nasdaq trackers, signaling confidence in broad-market rallies.